4basebio PLC (4BB.L) has a profit margin of -1114.69%, below the Healthcare sector average of 17.63%.
Get informed when a big investor buys or sells
+ FollowAs of Dec 2025
Trailing 12 months ending Dec 2025
4basebio PLC (4BB.L) currently reports a profit margin of -1114.69% as of December 2025. That compares with -1654.62% in the prior-year period — up 32.6% year over year. That is below the Healthcare sector average of 17.63%. Use the charts on this page to explore 4basebio PLC's profit margin history and peer comparisons.
4basebio PLC's profit margin increased from -1654.62% to -1114.69% — a 32.6% year-over-year increase (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
4basebio PLC's profit margin of -1114.69% is lower than the Healthcare sector average of 17.63%. That is roughly 6423.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but 4basebio PLC's current -1114.69% should be judged against Healthcare norms (sector average: 17.63%) and against 4BB.L's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -1114.69%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 17.63%. From there, open related valuation or income-statement pages for 4basebio PLC, and consider following 4BB.L for alerts when major investors trade the stock.